Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees

Annals of the Rheumatic Diseases

Volumn 56, Issue 5, 1997, Pages 299-307

  Belcher, Carolyn ^a   Yaqub, Reehana ^a   Fawthrop, Fiona ^a   Bayliss, Michael ^b   Doherty, Michael ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; EPITOPE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; KERATAN SULFATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; KNEE ARTHRITIS; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

EID: 0030974710     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.5.299     Document Type: Article

References (37)

1. Hardingham TE, Bayliss MT. Proteoglycans of articular cartilage: changes in ageing and in joint disease. Semin Arthritis Rheum 1990;20(suppl 1):12-33.
2. Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T. The antigenic determinants recognised by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly (N-acetyl-lactosamine) series. Eur J Biochem 1986; 157:385-91.
3. Thonar EJ-MA, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, et al. Quantification of keratan sulphate in blood as a marker of cartilage metabolism. Arthritis Rheum 1985;28:1367-76.
4. Mehraban F, Finegan CK, Moskowitz RW. Serum keratan sulphate. Quantitative and qualitative comparisons in inflammatory versus non-inflammatory arthritides. Arthritis Rheum 1991;34:383-92.
5. Campion GV, McCrae F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJ-MA. Levels of keratan sulphate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991;34:1254-9.
6. Sweet MBE, Coelho A, Schnitzer TJ, Lenz ME, Jakim I, Keuttner KE, et al. Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum 1988;31:557-60.
7. Spector TD, Woodward L, Hall GM, Hammond A, Williams A, Butler MG, et al. Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases. Ann Rheum Dis 1992;51:1134-7.
8. Block JA, Schnitzer TJ, Andersson GBJ, Lenz ME, Jeffery R, McNeill TW, et al. The effect of chemonucleolysis on serum keratan sulphate levels in humans. Arthritis Rheum 1989;32:100-4.
9. Sharif M, George E, Shepstone L, Knudson W, Thonar EJ-MA, Cushnaghan J, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995;38:760-7.
10. Caterson B, Mahmoodian F, Sorrell JM, Hardingham TE, Bayliss MT, Carney ST, et al. Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci 1990;97:411-7.
11. Visco DM, Johnstone B, Hill MA, Jolly GA, Caterson B. Immunohistochemical analysis of 3-B-3(-) and 7-D-4 epitope expression in canine osteoarthritis. Arthritis Rheum 1993;36:1718-25.
12. Slater RR, Bayliss MT, Lachiewicz PF, Visco DM, Caterson B. Monoclonal antibodies that detect biochemical markers of arthritis in humans. Arthritis Rheum 1995;38:655-9.
13. Hazell PK, Dent C, Fairclough JA, Bayliss MT, Hardingham TE. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 1995; 38:953-9.
14. Ledingham JM, Regan M, Jones A, Doherty M. Radiographic patterns and associations of knee osteoarthritis in a hospital referred population. Ann Rheum Dis 1993; 52:520-6.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Spector TD, Cooper C, Cushnaghan J, Hart DJ, Dieppe PA. A radiographic atlas of knee osteoarthritis. London: Springer-Verlag, 1992.
17. Doherty M, Richards N, Hornby J, Powell R. Relationship between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis and crystal associated arthropathy. Ann Rheum Dis 1988; 47:190-7.
18. Jones A, Hopkinson N, Pattrick M, Berman P, Doherty M. Evaluation of a method for clinically assessing osteoarthritis of the knee. Ann Rheum Dis 1992;51:243-5.
19. Hamilton E, Pattrick M, Doherty M. Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid. Br J Rheumatol 1991;30:260-4.
20. Ratcliffe A, Shurety W, Caterson B. The quantitation of a native chondroitin sulphate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy. Arthritis Rheum 1993; 36:543-51.
21. Fosang AJ, Hey NJ, Carney SL, Hardingham TE. An ELISA plate based assay for hyaluronan using biotinylated G1 domain (HA-binding region). Matrix 1990;10:306-13.
22. Farndale RW, Sayers C, Barrett AJ. A direct photospectro-photometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247-8.
23. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173-7.
24. Fawthrop F, Yaqub R, Belcher C, Bayliss M, Ledingham J, Doherty M. Chondroitin and keratan sulphate epitopes, glycosaminoglycans and hyaluronan in progressive versus non-progressive osteoarthritis. Ann Rheum Dis 1997; 56:119-22.
25. Doherty M, Belcher C, Regan M, Jones A, Ledingham J. Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis. Ann Rheum Dis 1996;55:432-6.
26. Zhang Y, Glynn RJ, Felson DT. Musculoskeletal disease research: should we analyse the joint or the person? J Rheumatol 1996;23:1130-4.
27. Saxne T, Heinegard D, Wollheim FA, Pettersson H. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet 1985;i:127-8.
28. Saxne T, Heinegard D. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum 1992;35:385-90.
29. Sharif M, Osborne DJ, Meadows K, Woodhouse SM, Colvin EM, Shepstone L, et al. The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid. Br J Rheumatol 1996;35:951-7.
30. CS-Szabo G, Roughley PJ, Plaas AHK, Giant TT. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum 1995;38:660-8.
31. Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967;10:357-76.
32. Dahl LB, Dahl IMS, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22.
33. Silverman B, Cawston TE, Page Thomas DP, Dingle JT, Hazleman BL. The sulphated glycosaminoglycan levels in synovial fluid aspirates in patients with acute and chronic joint disease. Br J Rheumatol 1990;29:340-4.
34. Ratcliffe A, Doherty M, Maini RN, Hardingham T. Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease. Ann Rheum Dis 1988;47:826-32.
35. Bensouyad A, Hollander AP, Dularay B, Bedwell AE, Cooper RA, Hutton CW, et al. Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arhritis. Ann Rheum Dis 1990;49:301-7.
36. Belcher C, Fawthrop F, Bunning R, Doherty M. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis 1996;55:230-6.
37. Lewis S, Crossman M, Doherty M, Bayliss M, Mason R. Characterisation by capillary electrophoresis of synovial fluid chondroitin sulphates in osteoarthritis. [Abstract]. Br J Rheumatol 1995;34 (suppl 1):54.